Generic Drugs Market in Japan 2015-2019
Generic Drugs Market in Japan 2015-2019 is the latest addition to Sandlerresearch.org industry research reports collection. A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. Generic drugs enter the market once the patent protection of the original developer expires. Generally, the cost of generic drugs is 50-70 percent lower than that of their brand-name counterparts, while meeting the very same standards of safety, quality, and efficacy as the innovator drugs. Generic drugs help the manufacturer by eliminating the need to develop and market a new drug. As the patent approaches expiration, manufacturers can apply to the FDA for approval to manufacture and sell generic versions of the drug. Generic drugs are equal to and within the bioequivalence range of branded drugs. Analysts forecast the Generic Drugs market in Japan to grow at a CAGR of 8.16 percent over the period 2014-2019. Covered in this Report The Generic Drugs market in Japan can be divided into three segments: Generic Prescription Medicines, Super Generics, and Biosimilars. This report covers the present scenario and the growth prospects of the Generic Drugs market in Japan for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the following segments:
Generic Prescription Medicines Super Generics Biosimilars
Generic Drugs market in Japan 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the Generic Drugs market in Japan and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Get discount on the Report @ http://www.sandlerresearch.org/discount?rname=31196 . Key Vendors
Meiji Seika Pharma Nichi-Iko Pharmaceutical Nipro Pharma
Sawai Pharmaceuticals Teva Pharmaceutical Industries Towa Pharmaceutical
Other Prominent Vendors
Actavis Daiichi Sankyo Daito Pharmaceutical Eisai Fuji Pharma GlaxoSmithKline Hikari Pharmaceutical Hospira Mylan Nihon Generic Nippon Chemipher Nippon Kayaku Nissin Pharmaceutical Ohara Pharmaceutical Pfizer Sandoz Taiyo Yakuhin Takeda Pharmaceutical Zensei Pharmaceutical Industries
Single User License of the Report is Available at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=31196 . Market Driver
Increase in Number of Patent Expiries
Market Challenge
Intense Competition among Vendors
Market Trend
Increase in M&A
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth?
Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Inquire Before buying the Report @ http://www.sandlerresearch.org/inquire-beforebuying?rname=31196 . Complete Report is Available @ http://www.sandlerresearch.org/generic-drugs-market-in-japan2015-2019.html . Browse All Reports on Pharmaceutical Market
Contact sales@sandlerresearch.org / Call +1 888 391 5441 for further information on “Generic Drugs Market in Japan 2015-2019” report OR for any other market research and intelligence needs you may have for your business.